📢 Too many exams? Don’t know which one suits you best? Book Your Free Expert 👉 call Now!

  • google app store apple app store

    • Question

      What is the production capacity of Biovet’s facility for

      the Lumpy Skin Disease (LSD) vaccine?
      A 100 million doses annually Correct Answer Incorrect Answer
      B 250 million doses annually Correct Answer Incorrect Answer
      C 500 million doses annually Correct Answer Incorrect Answer
      D 750 million doses annually Correct Answer Incorrect Answer
      E 1 billion doses annually Correct Answer Incorrect Answer

      Solution

      Biovet’s Mallur facility has a production capacity of 500 million doses annually for the Lumpy Skin Disease (LSD) vaccine. The vaccine was developed with ICAR’s support and underwent rigorous testing at ICAR-NRCE and IVRI before approval.

      Practice Next
      ask-question